Latest Technology Innovation News

VBX Limited has announced significant enhancements to its Wuudagu Bauxite Project, increasing mining rates and securing $2 million in funding to support an expanded feasibility study.

Appen Limited delivered a robust Q4 FY25, driven by explosive growth in its China segment and strong gains in generative AI projects globally, boosting revenue and profitability significantly.

PainChek has secured FDA-regulated medical device status, enabling US Remote Therapeutic Monitoring reimbursement and opening a major US growth avenue. The company targets musculoskeletal pain management in non-verbal dementia patients, a largely underserved market.

Nanoveu Limited has successfully raised $7.38 million through a strategic placement, advancing its position in advanced semiconductor and material sciences. The capital injection supports ongoing development of its innovative AI-driven SoC solutions and antimicrobial technologies.

VBX Limited’s latest metallurgical optimisation for the Wuudagu bauxite project reveals significant improvements in product recovery and quality, paving the way for increased production capacity and reduced operational costs.

Pureprofile has reported record first-half FY26 results, driven by strong international expansion and AI-powered platform growth, prompting an upgrade to its full-year revenue guidance.

Nanoveu’s subsidiary EMASS has successfully taped out its next-generation 16nm ECS-DoT ultra-low-power Edge AI system-on-chip, now entering production at TSMC. This milestone marks a significant step in scaling their proven 22nm platform to deliver enhanced performance and integration for always-on AI applications.

Control Bionics has partnered with Tobii Dynavox to pilot its NeuroNode technology across five US states, aiming to enhance communication access for users of augmentative devices.

Elevate Uranium Ltd has completed a $25 million capital raising and is nearing steady state operations of its U-pgrade pilot plant in Namibia, while expanding its uranium resource portfolio through extensive drilling and a strategic acquisition from Core Lithium Ltd.

Genetic Signatures reported a $3.3 million quarterly revenue with growing international sales and a robust cash position, while preparing for a leadership change.

Brazilian Critical Minerals has successfully demonstrated a 200-fold upgrade in rare earth element concentration using Rare Earth Technologies’ proprietary process, producing high-purity oxides at its Ema project.

Zeotech Limited is set to validate its zeolite-based methane biofilter in a six-month on-site trial at a North Burnett landfill, aiming to curb emissions by over 90%. This marks a critical step from lab success to real-world application, supporting Australia’s climate goals.